Amid rising reports about adverse reactions to COVID-19 vaccines, Dr. David Cartland, a GMC-registered General Practitioner, has urged individuals who suspect they may have experienced vaccine-related injuries to pursue specific medical tests. Dr. Cartland, who holds a First-Class Honors degree in Biomedical Science with expertise in immunology and virology, has recommended a series of screenings that could reveal underlying inflammatory or autoimmune responses in affected individuals.
In a message shared on social media, Dr. Cartland suggested that patients seek tests for autoantibodies and vasculitis markers, which may indicate an abnormal immune response potentially linked to COVID-19 vaccination.
He advised individuals to request screenings for anti-nuclear antibodies (ANA) and anti-neutrophil cytoplasmic antibodies (ANCA), as well as checks for general inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). These tests, Cartland claims, could reveal evidence of an immune system reaction associated with vaccine administration.
The tests recommended by Dr. Cartland each serve a specific diagnostic function. ANA and ANCA tests measure the presence of autoantibodies, which occur when the immune system mistakenly targets the body’s own tissues. Positive results in these tests may indicate autoimmune conditions or inflammatory responses, including vasculitis, an inflammation of blood vessels. Elevated levels of CRP and ESR, which measure inflammation within the body, can further signal an abnormal immune response.
Dr. Cartland’s call for testing comes after conducting a study involving 19 patients in early 2024. According to Cartland, every participant who reported suspected vaccine-related symptoms tested positive for ANA to varying degrees, suggesting a potential autoimmune response following vaccination.
Although small in scale, this study has led Cartland to advocate for expanded testing among individuals reporting similar symptoms, emphasizing that early detection of autoimmune markers could help manage symptoms and prevent complications.
One notable study by Rancourt et al. estimated approximately 17 million deaths globally attributed to COVID-19 vaccinations by September 2023. This figure highlights concerns about the widespread use of these vaccines and the potential risk of severe outcomes, a stark comparison to historical incidents, such as the 140,000 fatalities reported following the atomic bombing of Hiroshima in 1945.
Another significant study by Mostert et al. reported an estimated 3.1 million excess deaths related to COVID-19 vaccinations and pandemic lockdowns across 47 countries between 2020 and 2022.
These findings have intensified calls for further investigation into both the direct and indirect impacts of pandemic policies, particularly concerning vaccine safety and overall public health.
Individuals who suspect adverse reactions following COVID-19 vaccination may encounter challenges when seeking these tests, according to Dr. Cartland, who has described cases in which healthcare providers dismissed patients’ concerns. Dr. Cartland encourages individuals to be proactive in requesting these specific tests, noting that a positive diagnosis for autoimmune markers could enable affected individuals to receive appropriate medical interventions.